triazoles has been researched along with apomorphine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akahori, F; Arai, S; Ichimura, T; Masaoka, T | 1 |
| Moriya, R; Nagawa, Y; Nakajima, R; Saji, Y; Take, Y; Yui, T | 1 |
| Horiuchi, M; Ibii, N; Yamamoto, K | 1 |
| Abdala, S; Darias, V; Martin-Herrera, D; Tello, ML; Vega, S | 1 |
| Fenu, S; Morelli, M | 1 |
| Acquas, E; Di Chiara, G; Fenu, S; Loddo, P | 1 |
| Fredholm, BB; Halldner, L; Lindström, K; Lozza, G | 1 |
| Chawla, PS; Kochar, MS | 1 |
| Brown, CS; Moll, JL | 1 |
| Dixit, TS; Elased, KM; Lucot, JB; Sharma, AN | 1 |
| Grauer, SM; Hodgson, R; Hyde, LA | 1 |
2 review(s) available for triazoles and apomorphine
| Article | Year |
|---|---|
What's new in clinical pharmacology and therapeutics.
Topics: Abatacept; Acetanilides; Amides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiparkinson Agents; Antirheumatic Agents; Antiviral Agents; Apomorphine; Benzazepines; Cardiovascular Agents; Fumarates; Hepatitis B; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Hypoglycemic Agents; Immunoconjugates; Multiple Sclerosis; Natalizumab; Nucleosides; Papillomavirus Vaccines; Pharmacology, Clinical; Piperazines; Pyrazines; Pyrimidinones; Quinoxalines; Ranolazine; Sitagliptin Phosphate; Smoking Cessation; Telbivudine; Thymidine; Triazoles; Varenicline; Viral Vaccines | 2008 |
The use of monoamine pharmacological agents in the treatment of sexual dysfunction: evidence in the literature.
Topics: Antidepressive Agents, Second-Generation; Apomorphine; Biogenic Monoamines; Central Nervous System Stimulants; Dopamine Agonists; Evidence-Based Medicine; Humans; Piperazines; Sexual Dysfunction, Physiological; Sexuality; Triazoles | 2011 |
9 other study(ies) available for triazoles and apomorphine
| Article | Year |
|---|---|
Emetic effect of triazolopyrimidine, a pyrimidine compound, in dogs.
Topics: Animals; Apomorphine; Chlorpromazine; Dogs; Dose-Response Relationship, Drug; Emetics; Female; Male; Pyrimidines; Triazoles | 1985 |
Pharmacological studies on new potent central depressants, 8-chloro-6-phenyl-4H-s-triazolo [4,3a][1,4] benzodiazepine (D-40tA) and its 1-methyl analogue (D-65MT).
Topics: Administration, Oral; Aggression; Animals; Anticonvulsants; Antiemetics; Apomorphine; Avoidance Learning; Azepines; Behavior, Animal; Benzazepines; Cats; Central Nervous System; Chlordiazepoxide; Chlorprothixene; Diazepam; Discrimination Learning; Dogs; Drug Synergism; Female; Haplorhini; Hexobarbital; Humans; Injections, Intraperitoneal; Lethal Dose 50; Male; Mescaline; Methamphetamine; Mice; Morphine; Motor Activity; Muscle Relaxants, Central; Reserpine; Sleep; Tetrabenazine; Triazoles | 1971 |
[Pharmacology of a 1H-1, 2, 4-triazolyl benzophenone derivative (450191-S), a new sleep-inducer (III). Behavioral study on interactions of 450191-S and other drugs in mice].
Topics: Aminopyrine; Animals; Anti-Anxiety Agents; Apomorphine; Behavior, Animal; Benzodiazepines; Central Nervous System; Central Nervous System Agents; Haloperidol; Hypnotics and Sedatives; Imipramine; Male; Mice; Pentylenetetrazole; Phenytoin; Reserpine; Triazoles | 1984 |
CNS effects of a series of 1,2,4-triazolyl heterocarboxylic derivatives.
Topics: Animals; Anti-Anxiety Agents; Apomorphine; Behavior, Animal; Central Nervous System Agents; Dopamine Agonists; Drug Synergism; Female; Heterocyclic Compounds, 2-Ring; Hypnotics and Sedatives; Male; Mice; Motor Activity; Muscarinic Agonists; Muscle Relaxants, Central; Oxotremorine; Pentobarbital; Sleep; Triazoles | 1998 |
Motor stimulant effects of caffeine in 6-hydroxydopamine-lesioned rats are dependent on previous stimulation of dopamine receptors: a different role of D1 and D2 receptors.
Topics: Animals; Apomorphine; Caffeine; Central Nervous System Stimulants; Dopamine Agonists; Male; Motor Activity; Oxidopamine; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Stimulation, Chemical; Triazoles; Xanthines | 1998 |
A within-subjects microdialysis/behavioural study of the role of striatal acetylcholine in D1-dependent turning.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Animals; Apomorphine; Dizocilpine Maleate; Dopamine Agonists; Excitatory Amino Acid Antagonists; Indoles; Male; Medial Forebrain Bundle; Microdialysis; Neostriatum; Neuroprotective Agents; Phenanthridines; Pyrimidines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Sympathectomy, Chemical; Triazoles | 1999 |
Lack of tolerance to motor stimulant effects of a selective adenosine A(2A) receptor antagonist.
Topics: Animals; Apomorphine; Caffeine; Drug Tolerance; Genes, Immediate-Early; Male; Motor Activity; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Purinergic P1; RNA, Messenger; Triazoles | 2000 |
Antipsychotic-like effect of GLP-1 agonist liraglutide but not DPP-IV inhibitor sitagliptin in mouse model for psychosis.
Topics: Animals; Antipsychotic Agents; Apomorphine; Disease Models, Animal; Dopamine Agonists; Glucagon-Like Peptide 1; Liraglutide; Male; Mice; Psychotic Disorders; Pyrazines; Sitagliptin Phosphate; Statistics, Nonparametric; Triazoles | 2013 |
MitoPark mice, an animal model of Parkinson's disease, show enhanced prepulse inhibition of acoustic startle and no loss of gating in response to the adenosine A(2A) antagonist SCH 412348.
Topics: Adenosine A2 Receptor Antagonists; Aging; Animals; Apomorphine; Benzothiazoles; Disease Models, Animal; Dopamine Agonists; Male; Mice; Mice, Transgenic; Motor Activity; Parkinson Disease; Pramipexole; Prepulse Inhibition; Pyrimidines; Triazoles | 2014 |